For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Human AML cells
Our Abpromise guarantee covers the use of ab7417 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|Functional Studies||Use at an assay dependent concentration. The antibody WM15 inhibits infection of cells by human coronavirus and inhibits aminopeptidase N activity of the CD13 molecule immunoprecipitates.|
|WB||Use at an assay dependent concentration. Predicted molecular weight: 110 kDa.|
|ELISA||Use at an assay dependent concentration.|
|Flow Cyt||Use a concentration of 5 µg/ml.|
|IHC-Fr||Use at an assay dependent concentration.|
|IP||Use at 10 µg/mg of lysate.|
|ICC/IF||Use a concentration of 10 µg/ml. See Abreview.|
|IHC-P||Use at an assay dependent concentration.|
ab7417 staining CD13 in Human brain tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with formaldehyde and blocked with 1% serum for 20 minutes; antigen retrieval was by heat mediation in a citrate buffer. Samples were incubated with primary antibody (1/400) for 18 hours at 20°C. An undiluted HRP-conjugated Horse anti-mouse IgG polyclonal was used as the secondary antibody.